ID: ALA5218531

Max Phase: Preclinical

Molecular Formula: C11H15NO3

Molecular Weight: 209.25

Associated Items:

Representations

Canonical SMILES:  CN1C(=O)[C@@]2(C)[C@@H]3CC[C@@H](O3)[C@@]2(C)C1=O

Standard InChI:  InChI=1S/C11H15NO3/c1-10-6-4-5-7(15-6)11(10,2)9(14)12(3)8(10)13/h6-7H,4-5H2,1-3H3/t6-,7+,10+,11-

Standard InChI Key:  WUQNOBSCYAIJIH-FIPCFZRWSA-N

Associated Targets(Human)

Hep 3B2 2332 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 209.25Molecular Weight (Monoisotopic): 209.1052AlogP: 0.56#Rotatable Bonds: 0
Polar Surface Area: 46.61Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 0.55CX LogD: 0.55
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.55Np Likeness Score: 1.31

References

1. Ren Y, Kinghorn AD..  (2021)  Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.,  32  [PMID:33454654] [10.1016/j.bmc.2021.116012]

Source